ESCRS - OPHTHALMALOGICA – Peer-reviewed journal of EURETINA ;
ESCRS - OPHTHALMALOGICA – Peer-reviewed journal of EURETINA ;

OPHTHALMALOGICA – Peer-reviewed journal of EURETINA

Vol 236 Issue 3, edited by Sebastian Wolf

OPHTHALMALOGICA –  Peer-reviewed journal of EURETINA
Sebastian Wolf
Published: Monday, December 5, 2016
opthalmologica   CLOT-BUSTER EFFECTIVE IN SUBRETINAL HAEMORRHAGES Vitrectomy combined with subretinal rtPA injection and gas or air tamponade can improve vision and reduce lesion size in eyes with subretinal haemorrhages (SRHs) alone and with combined subretinal and subpigment epithelial haemorrhages (SPHs). The treatment also seems to slightly improve the anatomical outcome in eyes with SPH alone, an observational study suggests. It showed that among 19 eyes with SRH and 53 eyes with combined haemorrhages, the mean best corrected visual acuity (BCVA) improved significantly following treatment. There were also significant reductions in maximal haemorrhage diameter (MHD), and central macular thickness (CMT) (p<0.05). M Waizel et al, “Efficacy of Vitrectomy Combined with Subretinal Recombinant Tissue Plasminogen Activator for Subretinal versus Subpigment Epithelial versus Combined Haemorrhages”; Ophthalmologica 2016, Volume 236, Issue 3. HIGH INTRAVITREAL VEGF LEVELS PREDICT WORSE VITRECTOMY OUTCOMES Patients with proliferative diabetic retinopathy (PDR) who have higher levels of intravitreal vascular endothelial growth factor (VEGF) have a significantly worse postoperative visual acuity following vitrectomy than those with lower levels, a new study suggests. It showed that, among 136 eyes of 114 PDR patients vitrectomised between 2006 and 2008, corrected visual acuity six months after surgery was significantly worse in those with intravitreal VEGF levels 5,000 pg/mL or higher than it was in those with higher levels of the growth factor (p=0.02). Reoperations were also significantly less common among those with low VEGF levels. Y Suzuki et al, “Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy”; Ophthalmologica 2016, Volume 236, Issue 3. HYPHAEMA FOLLOWING VITRECTOMY High myopia and scleral buckling procedures combined with vitrectomy are risk factors for postoperative hyphaema following surgery for primary rhegmatogenous retinal detachment (RRD), a new study suggests. Among 1,011 consecutive eyes that underwent surgery for RRD, 32 had postoperative hyphaema. A comparison between eyes with and without the complication indicated that the likelihood of hyphaema was over three times higher among high myopes (odds ratio 3.396; p=0.003), and over 20 times higher among those who underwent a combined scleral buckling-vitrectomy procedure (OR 21.266; p<0.001), than among the patients overall. Y Kung et al, “Risk Factors for Hyphema following Surgeries for Primary Rhegmatogenous Retinal Detachment”; Ophthalmologica 2016, Volume 236, Issue 3.
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;